Yichang HEC ChangJiang reports stable share capital for June

Yichang HEC ChangJiang Pharmaceutical Co., Ltd. reported no changes to its authorized or issued share capital for the month ended June 30, 2025. The company's authorized share capital remains at 653,767,700 H shares and 226,200,000 domestic shares, with an equivalent number of issued shares, respectively. Both H shares and domestic shares have a par value of RMB 1. At the end of June, the total authorized/registered share capital stood at RMB 879,967,700. The filing, a standard monthly return, indicates no activity related to share options, warrants, convertibles, or other agreements affecting share issuance during the reporting period.